Impact Biomedical Inc.'s ability to collect accounts receivable sequentially worsen to 0.18, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Impact Biomedical's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 2028 days, from 1921 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector IMPACT BIOMEDICAL INC. achieved the highest receivable turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3410, from overall ranking in the first quarter 2026 at 3740.

What is Receivable Turnover Ratio?
What is Impact Biomedical Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IBO Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-1.5 %	-0.5 %	-49.5 %	-1 %	-39.39 %
Y / Y Revenue Change	-57.14 %	-	-	-	-
Receivable Turnover Ratio (TTM)	0.18	0.19	0.16	0.1	0.03
IBO's Total Ranking	# 3410	# 3740	#	#	#
Accounts Receivable average collection period days	2081	1874	2287	3654	13075
Seq. Receivable Change	-1.01 %	-1.97 %	2.01 %	-0.5 %	0 %
Seq. Revenue Change	-57.14 %	0 %	-61.11 %	157.14 %	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 0
Healthcare Sector	# 0
Overall Market	# 3410

Receivable Turnover Ratio Statistics
High	Average	Low
0.1	0.1	0.1
(Mar 31 2026)

IBO Company Profile • Back to IBO Efficiency Comparisons • Compare IBO Receivables Turnover Ratio to its Competitors

Financial Statements
Impact Biomedical's Accounts Receivable	$ 0 Millions	Visit IBO's Balance sheet
Impact Biomedical's Sales TTM	$ 0 Millions	Visit IBO's Income Statement
Sources of IBO's Revenues		Visit IBO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IBO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IBO's Growth Rates	IBO's Roa	IBO's Inventory Turnover Ratio	IBO's Dividend Comparisons
IBO's Profitability Ratios	IBO's Roi	IBO's Asset Turnover Ratio	IBO's Dividend Growth
IBO's Valuation Ratios	IBO's Roe	IBO's Financial Strength Ratios	IBO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Cardiff Lexington Corporation	0.46	$ 10.213 Millions	$ 22.347 Millions
IMPACT BIOMEDICAL INC.	0.09	$ 0.035 Millions	$ 0.398 Millions

Date modified: 2026-08-14T20:25:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.